Delta Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Delta Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,825	Closed	-$215K	–	205
2023 Q1	$215K	Hold	2,825	–	–	0.06%	173
2022 Q4	$234K	Hold	2,825	–	–	0.08%	157
2022 Q3	$224K	Hold	2,825	–	–	0.1%	150
2022 Q2	$210K	Sell	2,825 -232	-8%	-$17.4K	0.1%	124
2022 Q1	$275K	Hold	3,057	–	–	0.08%	120
2021 Q4	$342K	Hold	3,057	–	–	0.1%	133
2021 Q3	$384K	Hold	3,057	–	–	0.12%	115
2021 Q2	$414K	Hold	3,057	–	–	0.12%	115
2021 Q1	$415K	Buy	3,057 +1	+0%	+$150	0.13%	109
2020 Q4	$430K	Buy	3,056 +4	+0.1%	+$512	0.14%	112
2020 Q3	$340K	Buy	3,052 +2	+0.1%	+$224	0.18%	87
2020 Q2	$341K	Buy	3,050 +1	+0%	+$98	0.14%	98
2020 Q1	$236K	Hold	3,049	–	–	0.18%	71
2019 Q4	$290K	Buy	+3,049	New	+$264K	0.11%	107

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Delta Investment Management's XBI Position: Q2 2023 in Review

Delta Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 2,825 shares — an estimated $215K sold.

Delta Investment Management first reported a position in XBI in Q4 2019 and held it in 14 quarters. The position peaked at $430K in Q4 2020. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Delta Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
Delta Investment Management sold 2,825 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $215K.
Delta Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 14 quarters.
Delta Investment Management's State Street SPDR S&P Biotech ETF position peaked at $430K in Q4 2020.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Delta Investment Management's 13F filing for Q2 2023, filed 4 Aug 2023.